`
`Helsinn Healthcare Exhibit 2065
`Dr. Reddy's Laboratories, Ltd., et al. v. Helsinn Healthcare S.A.
`Trial PGR2016-00007
`
`
`
`Receipt date: 10/02/2013
`
`13901437 - GAU: 1628
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary)
`
`Complete if Known
`1 3/901 .437
`
`May 23- 2013
`°'°'9'° °"L°ER"R' 9‘ 3"
`
`Shir|ey V, Gembeh
`24416800000‘/US8
`
`NONPATENT LITERATURE DOCUMENTS
`Plaintiffs’ Responses to Teva Pharmaceuticals USA, Inc. and Teva Phannaceutical Industries, Ltd.'s First
`Amended Invalidity Contentions, dated August 19, 2013 (D.N.J. Case Nos. 11-3962 and 11-5579;
`consolidated) (confidentiality designation redacted).
`Opening Expert Report of Dr. Bert Spilker, dated September 9, 2013 (D.N.J. Case Nos. 11-3962 and 11-
`5579; consolidated) (confidentiality desinalion and other portions redacted).
`Expert Report of David G. Frame, Pharm.D., dated September 5, 2013 (D.N.J. Case Nos. 11-3962 and 11-
`5579; consolidated) (confidentiality designation and other portions redacted).
`Expert Report of Lee Kirsch, Ph.D., dated September 9, 2013 (D.N.J. Case Nos. 11-3962 and 11-5579;
`consolidated) (confidentiality designation and other portions redacted ).
`Expert Report of Patrick P. DeLuca, Ph.D., dated September 9, 2013 (D.N.J. Case Nos. 11-3962 and 11-
`5579; consolidated) (confidentiality desination and other portions redacted).
`Expert Report of Paul Myrdal, Ph.D., dated September 9, 2013 (D.N.J. Case Nos. 11-3962 and 11-5579;
`consolidated) (confidentiality designation and other portions redacted).
`Complaint for patent infringementfiled by Helsinn Healthcare SA. and Roche Palo Alto LLC against
`Ben Venue Laboratories, Inc. dlbla Bedford Laboratories regarding U.S. Patent Nos. 7,947,724, 7,947,725,
`7,960,424, and 8.518.981 dated September 25, 2013 (D. Del Case No. 13-1612)
`Complaint for patent infringement filed by Helsinn Healthcare S.A. and Roche Palo Alto LLC against
`Dr. Reddy‘s Laboratories, Ltd., Dr. Reddy's Laboratories, lnc., Sandoz |nc., Teva Pharmaceuticals USA,
`Inc., and Teva Pharmaceutical Industries, Ltd. regarding U.S. Patent No. 8,518,981 dated September 30,
`2013 (D.N.J. Case No. (123-5815)).
`
`We Gembem/I07/2013 —
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in oonforrnance and not considered. Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/S.G./'
`
`Page 2 of 2